Best Pathology Software for Microsoft 365

Labs don't need another LIMS. They need a complete operating system for modern lab operations - and that's QBench, reshaping everything from order placement through sample processing to automated reporting. Simple. Powerful. Adaptable. Where other LIMS force labs into rigid structures built on heavy custom code and vendor dependency, QBench moves with you. It bends. It adapts. Your processes evolve, and QBench evolves too. It adapts to your secret sauce. Every lab has its own workflow, its own rhythm, and QBench respects that with unmatched configurability. You shape the workflows. You define the data fields. You stitch together the automations. QBench's former bench scientists work alongside you throughout, offering expert guidance and workflow suggestions. It automates the tedious work. File parsers and a robust API connect QBench to the instruments and systems you already run, so data flows on its own. No manual entry. No transcription errors. It unifies everything in one platform. Real-time inventory. A dedicated portal giving clients instant access to results. Built-in analytics. A QMS module that keeps you audit-ready, always. QBench helps labs work smarter - cloud-based, secure, and always evolving, like the science it supports.

Aiforia provides advanced deep learning and cloud-based solutions to pathologists and researchers in both preclinical and clinical laboratories, enhancing their capabilities in image analysis and workflow efficiency. By enabling scientists to discover new disease biomarkers and assisting R&D professionals in accelerating the market introduction of innovative drugs, Aiforia plays a crucial role in improving cancer diagnostic accuracy while revolutionizing healthcare from the initial discovery phase through to diagnosis. For clinical pathology laboratories seeking to boost efficiency and elevate the precision of their diagnoses, the Aiforia Clinical Suites present a comprehensive range of AI-driven diagnostic tools, intelligent visualization, quality control, and automated pre- and post-screening functionalities. We are in the process of developing specialized Suites targeting some of the most common cancers globally and have achieved CE-IVD certification for our AI solutions in lung and breast cancer, positioning us as a leader in diagnostic innovation. Our commitment to enhancing patient outcomes through technology underscores the transformative potential of our offerings in the healthcare sector.